Search results
Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Pari...
PharmiWeb· 2 days agoPARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 1, 2024 / Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized ...
Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Pari
PharmiWeb· 2 days agoParis (France) and Cambridge (Massachusetts, USA), July 01st, 2024 – 07:00am CET – Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology ...